logo

For the Inventor, By the Inventor

Tokyo, Japan

Shinji Tonomura

This inventor holds 56 USPTO granted patents, primarily in Pharmaceutical Chemistry (CPC class 4242). Top assignees: Mitsubishi Chemical Industries Limited, Shosuke Okamoto, Other. Active years: 1976-1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shinji Tonomura. Retrieved from https://idiyas.com/inventor/shinji-tonomura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 56

% Patents Active = 100.0

Average Co-Inventor Count = 6.1

ph-index = 15

Forward Citations = 743(Granted Patents)

Forward Citations (Not Self Cited) = 654(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Tokyo, JA (1976 - 1978)
  • Machida, JP (1981)
  • Tokyo, JP (1978 - 1987)
  • Kanagawa, JP (1988)

Company Filing History:

goldMedal56 out of 614 
 
Mitsubishi Chemical Industries Limited
 patents
silverMedal4 out of 5 
 
Shosuke Okamoto
 patents
bronzeMedal39 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 1976-1988

Loading Chart...
Areas of Expertise:
L-Arginine Derivatives
Pharmaceutical Salts
Active Compounds
Arylsulfonyl Derivatives
Naphthalenesulfonyl Compounds
Omega-Aminoalkoxy
Pharmaceutically Acceptable
Sulfonyl-Argininamides
2-Substituted Compounds
Pharmaceutical Chemistry
Tokyo, JP
56 patents (USPTO):Explore Patents
1. 4764618 - Arginine derivatives and pharmaceutically acceptable acid addition salts (1988-08-16),
2. 4670420 - N.sup.2 -dansyl-L-arginine derivatives, and the pharmaceutically (1987-06-02),
3. 4562211 - Pharmaceutically active 2-substituted-1-(omega-aminoalkoxy)benzenes (1985-12-31),
4. 4258192 - N.sup.2 -Arylsulfonyl-L-argininamides and the pharmaceutically (1981-03-24),
5. 4227006 - N.sup.2 -Dansyl-L-arginine derivatives, and the pharmaceutically (1980-10-07),
6. 4201863 - N.sup.2 -Arylsulfonyl-L-argininamides and the pharmaceutically (1980-05-06),
7. 4173630 - N.sup.2 Arylsulfonyl-L-argininamides and the pharmaceutically acceptable (1979-11-06),
8. 4168307 - N.sup.2 -Naphthalenesulfonyl-L-arginine derivatives, and the (1979-09-18),
9. 4154828 - N.sup.2 -Naphthalenesulfonyl-L-arginine derivatives, and the (1979-05-15),
10. 4140681 - N.sup.2 -Arylsulfonyl-L-argininamides and the pharmaceutically (1979-02-20),
11. 4139529 - N.sup.2 -Naphthalenesulfonyl-L-arginine derivatives and the (1979-02-13),
12. 4133880 - N.sup.2 -Substituted-L-arginine derivatives and the pharmaceutically (1979-01-09),
13. 4131673 - N.sup.2 -arylsulfonyl-L-argininamides and the pharmaceutically (1978-12-26),
14. 4125619 - N.sup.2 -naphthalenesulfonyl-L-arginine derivatives and the (1978-11-14),
15. 4125604 - N2-Arylsulfonyl-L-argininamides and the pharmaceutically acceptable (1978-11-14),

Title: Innovator Spotlight: Shinji Tonomura - Pioneering Inventor from Tokyo

Introduction:

Shinji Tonomura, a distinguished inventor hailing from Tokyo, Japan, has made significant contributions to the field of pharmaceuticals with a remarkable portfolio of 56 patents. His innovative work in developing novel arginine derivatives has revolutionized the realm of pancreatitis remedies.

Latest Patents:

Tonomura's latest patents showcase his expertise in creating arginine derivatives with trypsin-inhibiting activity, essential for treating pancreatitis. These derivatives, along with their pharmaceutically acceptable salts, have demonstrated promising results in providing effective remedies for pancreatic disorders.

Career Highlights:

Having worked at Mitsubishi Chemical Industries Limited and other reputable organizations, Tonomura has honed his skills and knowledge in pharmaceutical research and development. His career highlights include a track record of breakthrough innovations that have garnered attention in the scientific community.

Collaborations:

Throughout his career, Tonomura has collaborated with esteemed professionals in the field, such as Ryoji Kikumoto and Shosuke Okamoto. These collaborations have fueled his inventive spirit, leading to the successful creation of impactful pharmaceutical solutions.

Conclusion:

In conclusion, Shinji Tonomura stands out as a visionary inventor whose dedication to advancing pharmaceutical science has resulted in numerous groundbreaking patents. His contributions to the field of pancreatitis treatment underscore his commitment to innovation and improving healthcare outcomes. Tonomura's innovative spirit continues to inspire aspiring inventors and researchers worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…